Siemens AG (Germany), PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Bioscan, Inc. (U.S.), Mediso Medical Imaging Systems (Hungary), Gamma Medica (U.S.), FUJIFILM Holdings Corporation (Japan), Aspect Imaging (Israel)
(PRWEB) April 08, 2014
The report "Global Pre-clinical Imaging (In vivo) Market By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT Multimodality/Hybrid Imaging Modalities] - Competitive Analysis Global Forecasts to 2017"- analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.
Browse 117 market data tables and 20 figures through 270 pages and in-depth TOC of "Pre-Clinical Imaging (In vivo) Market"
Early buyers will receive 10% customization on this report.
The global pre-clinical imaging (in vivo) market consists of standalone, multimodal imaging devices and imaging reagents. The global pre-clinical in vivo imaging market is estimated at ~$790 million in 2012 and is poised to grow at a CAGR of 14.5% to reach ~$1,552 million by 2017.
Download Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=841.
The global pre-clinical imaging (in vivo) market has witnessed challenging and dynamic market conditions over the last couple of years, and is valued at $789.4 million in 2012 with an estimated annual growth rate of 14.5% over the next five years. Pre-clinical in vivo imaging industry has experienced myriad technological advancements, changes in market due to industry consolidation, and change in government funding and support for research studies across the global over the past decade. It is expected that the trend of product development and modification will continue in future to solve the present challenges and unmet needs of the market. Market displays growing preference for hybrid technologies such as SPECT+CT and PET + CT. This trend is expected for novel combination systems such as SPECT + MRI and PET + MRI. The global pre-clinical imaging (in vivo) market is expected to show growth over the long term due to driving factors such as technological advancements, growing adoption rate for pre-clinical imaging, rising application of functional imaging and increasing number of pharma companies and research institutions.
Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=841.
Imaging systems can be divided into standalone imaging systems and multimodal imaging systems. Standalone imaging systems are further classified into nuclear imaging, optical imaging, Micro-MRI, Micro-CT and Micro-Ultrasound. Multimodal imaging systems are classified into multimodal nuclear imaging devices and multimodal optical imaging devices. Imaging reagents can be divided into nuclear imaging agents, optical imaging agents, MRI contrasting reagents, CT contrast reagents and ultrasound contrast reagents.
North America is the largest market for pre-clinical imaging (in vivo) market, followed by Europe. However, emerging markets from regions such as Asia-Pacific and Latin America represent the fastest growing markets due to factors such as growing government support for research, increasing number of pre-clinical research studies, rising awareness and adoption of new imaging technologies, growing industry partnerships with research institutions and CROs and redefined focus of pre-clinical imaging systems suppliers on various market avenues in developing markets.
This report includes company profiles of major players such as Siemens AG (Germany), PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Bioscan, Inc. (U.S.), Mediso Medical Imaging Systems (Hungary), Gamma Medica (U.S.), FUJIFILM Holdings Corporation (Japan), Aspect Imaging (Israel), Miltenyi Biotec GmbH (Germany), Life Technologies Corporation (U.S.), Scanco Medical (Switzerland), and Targeson, Inc. (U.S.).
Browse Related Reports:
Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017
Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets